NCT06332209 Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico
| NCT ID | NCT06332209 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Post-Traumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-04-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current study will evaluate TF-CBT delivered via tele-health for youth presenting with trauma symptoms via a randomized controlled trial. Goals of the current study are to examine the effectiveness of Tele-TF-CBT delivered by community providers in Puerto Rico in improving youth trauma outcomes. Goals are also to support the feasibility, acceptability, and engagement outcomes of Tele-health delivery.
Eligibility Criteria
Inclusion Criteria: * 7-18 years old * experienced at least one traumatic event * present with clinically significant levels of post-traumatic stress symptoms Exclusion Criteria: * significant suicidal ideation * substance use disorder * active psychotic symptoms * pervasive developmental delays, * currently living with or in close contact with the perpetrator of their abuse
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06332209 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 18 Years, studying Post-Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06332209 currently recruiting?
Yes, NCT06332209 is actively recruiting participants. Contact the research team at stewartr@musc.edu for enrollment information.
Where is the NCT06332209 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06332209 clinical trial?
NCT06332209 is sponsored by Medical University of South Carolina. The trial plans to enroll 80 participants.